Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Johnson and Johnson

Johnson and Johnson News Editors

News Widget

Display the Johnson and Johnson news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Johnson and Johnson News

News on Johnson and Johnson (Ticker: JNJ) continually updated from thousands of sources around the net.

17 min ago | SBWire

NYSE Gainers Watch List: Verizon Communications Inc. (NYSE:VZ) and...

Growing Stock Report expands its NYSE Gainers Weekly Watch List adding Verizon Communications Inc. and Johnson & Johnson .

Comment?

Related Topix: Telecom, Advanced Solutions International, IT Services, Terremark Worldwide, Access Northeast, Software, Verizon Communications, Biotech, Medicine, Healthcare Industry, Verizon

4 hrs ago | Illinoisreview

Thorner: Shortchanging of Secretary of HHS Scandal

All posts, comments and statements made on IR are those of the authors only. Any disputes must be addressed to the writers, who are solely responsible for their posts, comments and statements.

Comment?

Related Topix: US News, Healthcare Law, Law, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

8 hrs ago | Fox News

Call for overhaul of drug industry business model

Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says.

Comment?

Related Topix: Oncology, Medicine, Johnson & Johnson, Biotech, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

12 hrs ago | The News-Press

7-Eleven expands locally

The familiar red and green 7-Eleven sign is getting even more commonplace across Southwest Florida as the company targets the region for a major expansion effort.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Lehigh Acres, FL

Tue Jun 18, 2013

The Motley Fool

It Might Be Time to Take Profits in Blue Chip Dividend Payers

James is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.

Comment?

Related Topix: Blog News, Financial Markets, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Las Cruces Sun-News

Ark. AG seeks to uphold verdict against J&J

Arkansas' attorney general filed a brief Tuesday backed by his counterparts in 35 other states asking the Arkansas Supreme Court to uphold a $1.2 billion fine levied against Johnson & Johnson and a subsidiary over the marketing of the antipsychotics drug Risperdal.

Comment?

Related Topix: Food, J and J Snack Foods, Arkansas, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

KSLA-TV Shreveport

Ark. AG seeks to uphold verdict in drug case

Arkansas Attorney General Dustin McDaniel is asking the state's highest court to uphold a $1.2 billion fine leveled against Johnson and Johnson and a subsidiary over the marketing of an antipsychotic drug.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Insider Monkey

Eli Lilly & Co. (LLY), Alkermes Plc (ALKS): The FDA Might Pull This...

The Food and Drug Administration is investigating two deaths that occurred after patients were injected with Eli Lilly & Co.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Alkermes, Food and Drug Administration

SchaeffersResearch.com

Option Trends: Johnson & Johnson

Speculative players have been taking sides on blue chip Johnson & Johnson , automaker General Motors Company , and Finnish telecom concern Nokia Corporation , according to data from the major options exchanges.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls, Opinion

TheStreet.com

Johnson & Johnson Gets Key Cancer Drug With Aragon Buy

Aside from concerns about the company's valuation, I didn't feel comfortable about Johnson & Johnson's margins; nor did I feel that the company's top-selling drug, Zytiga, was the answer to long-term prosperity.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

SBWire

Keep Up-to-Date with Current Health Sector Issues : Johnson & Johnson ...

Johnson & Johnson said Thursday it has decided to buy Aragon Medication Inc. for at least $650 thousand in money, enhancing its position in prostate medication growth.The independently owned San Paul organization is targeted on the growth of medication to cure hormonally motivated malignancies.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Medical Daily

New Teardrop MemoryShape Silicone Gel Breast Implants Approved By...

With the approval of a new teardrop MemoryShape silicone breast implant, fears over the development of cancer from such implants have finally been addressed.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Food and Drug Administration, Breast Enlargement, Women's Health, Health

Mon Jun 17, 2013

Bioscience Technology

FDA approves new silicone breast implant from J&J

The Food and Drug Administration said Friday it approved a next-generation silicone breast implant from Johnson & Johnson unit Mentor.

Comment?

Related Topix: Food, J and J Snack Foods, Food and Drug Administration, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Reuters

UPDATE 2-J&J in $1 bln deal to bolster prostate-cancer focus

Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment four years ago that has become a leading brand.

Comment?

Related Topix: Food, J and J Snack Foods, Medicine, Cancer, Health, Prostate Cancer, Johnson & Johnson, Biotech, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

AmericanBankingNews.com

Johnson & Johnson's Neutral Rating Reaffirmed at Sterne Agee

's stock had its "neutral" rating restated by equities researchers at Sterne Agee in a research report issued on Monday, StockRatingsNetwork.com reports.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Fox News

J&J to Acquire Privately-Held Aragon Pharma

Johnson & Johnson agreed to buy privately-held drug developer Aragon Pharmaceuticals for as much as $1 billion on Monday as it looks to build-out its portfolio of drugs that treat hormonally-driven diseases like prostate cancer.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

Monster.com

Staff Sterilization Scientist Job

Johnson & Johnson companies are equal opportunity employers. STAFF STERILIZATION SCIENTIST-0836130204 Description The Ethicon Surgical Care business a member of Johnson & Johnson&'s Family of Companies, is currently recruiting for a Staff Sterilization Scientist located in Albuquerque, NM.

Comment?

Related Topix: Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Johnson Controls, LOC-AID Technologies

Sun Jun 16, 2013

Reuters

UK scientists win funding for new kind of anticoagulant drug

British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a previously unachievable goal.

Comment?

Related Topix: Biotech, GlaxoSmithKline, Johnson & Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

Bloomberg

Johnson & Johnson's Depuy Synthes Wins $16 Million for Patents

Johnson & Johnson's DePuy Synthes unit, a maker of artificial spinal repair products, won $16 million in damages from Globus Medical Inc. when a jury decided that three of its patents were infringed.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Wilmington, DE

Patch.com

Job Roundup for Sunday, June 16

The following job opportunities were listed as available in or near Oconee County last week.

Comment?

Related Topix: Oconee County, GA, Watkinsville, GA, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Ashburn Jobs